CareDx (CDNA) director receives 1,746-share quarterly stock grant as compensation

Rhea-AI Filing Summary

Goldberg Michael reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director Michael Goldberg reported an automatic equity grant and updated holdings. He received a grant of 1,746 shares of Common Stock at $0.00 per share as quarterly non-employee director compensation in lieu of cash under the company’s Outside Director Compensation Policy.

Following this grant, Goldberg holds 106,438 Common Stock shares directly. A separate entry shows 91,045 Common Stock shares held indirectly by the Cavallo Trust, for which Goldberg and his spouse serve as trustees. The filing reflects routine compensation and ownership reporting rather than open-market buying or selling.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Goldberg Michael

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,746	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 106,438 shares (Direct, null); Common Stock — 91,045 shares (Indirect, See Footnote)

Footnotes (1)

1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

Key Figures

Director stock grant: 1,746 shares Grant price: $0.00 per share Direct holdings after grant: 106,438 shares +3 more

6 metrics

Director stock grant 1,746 shares Automatic quarterly grant at $0.00 per share for director compensation

Grant price $0.00 per share Issue price of Common Stock granted as non-employee director compensation

Direct holdings after grant 106,438 shares Common Stock directly held by Michael Goldberg following the transaction

Indirect trust holdings 91,045 shares Common Stock held by the Cavallo Trust with Goldberg and spouse as trustees

Acquire-type transactions 1 transaction Form 4 transaction summary shows one acquisition entry

Holding entries 1 entry Form 4 includes one holding line for Cavallo Trust shares

Key Terms

Form 4, Common Stock, Outside Director Compensation Policy, non-employee director compensation, +2 more

6 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4): { "issuerName": "CareDx, Inc.","

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

""security_title": "Common Stock", "transaction_date": "2026-07-02T00:00:00.000Z""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Outside Director Compensation Policy financial

"director compensation pursuant to the issuer's Outside Director Compensation Policy."

non-employee director compensation financial

"grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation"

indirect ownership financial

""ownership_type": "indirect", "ownership_code": "I""

Cavallo Trust financial

"Represents shares held by the Cavallo Trust of which the Reporting Person"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 05:54 PM Accepted by SEC EDGAR 07/07/2026 - 05:53 PM Learn about SEC filing dates

FAQ

What insider transaction did CareDx (CDNA) director Michael Goldberg report?

Michael Goldberg reported an automatic grant of 1,746 CareDx common shares as non-employee director compensation. The shares were issued at $0.00 per share in lieu of cash, under CareDx’s Outside Director Compensation Policy, and represent routine equity-based board compensation.

How many CareDx (CDNA) shares does Michael Goldberg hold after this Form 4?

After the reported grant, Michael Goldberg holds 106,438 CareDx common shares directly. The filing also notes 91,045 additional shares held indirectly by the Cavallo Trust, where Goldberg and his spouse act as trustees, giving a fuller picture of his reported ownership.

Was the CareDx (CDNA) Form 4 transaction an open-market purchase or sale?

The Form 4 does not show an open-market purchase or sale. Instead, it reports an automatic quarterly equity grant of 1,746 common shares at $0.00 per share, received as non-employee director compensation in place of cash fees under the company’s board compensation policy.

What is the Cavallo Trust mentioned in the CareDx (CDNA) Form 4?

The Cavallo Trust is an entity that holds 91,045 CareDx common shares reported as indirect ownership for Michael Goldberg. According to the filing, Goldberg and his spouse serve as trustees of the trust, and these trust-held shares are reported as part of his overall holdings.

How is Michael Goldberg compensated as a non-employee director of CareDx (CDNA)?

Michael Goldberg receives a portion of his non-employee director compensation in CareDx stock instead of cash. The Form 4 notes an automatic quarterly grant of 1,746 common shares at $0.00 per share, issued pursuant to CareDx’s Outside Director Compensation Policy for board members.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Michael

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026		A		1,746(1)	A	$0	106,438	D
Common Stock								91,045	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

2. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)